Joe’s auto-injector is designed to restart breathing in critical situations like opioid overdoses, drownings, and respiratory failures. Joe shares the journey behind his invention, he dives into the challenges of navigating the complex pharmaceutical industry, the delays caused by regulatory hurdles, and the importance of keeping life-saving tools accessible and affordable.
Key Points

• Joe’s auto-injector pen provides a new way to restart breathing during critical emergencies.
• The auto-injector is based on a reformulated, FDA-approved molecule that has been used safely since the 1960s.
• The journey to bring a life-saving product to market is filled with regulatory hurdles, delays, and high costs.
• The reasons behind Joe’s decision to leave a secure anesthesiology career.
• The high administrative costs and bureaucratic inefficiencies that drive up healthcare prices.
• Direct Primary Care models and cash-pay surgery centers reduce costs and improve patient outcomes.
• Joe hints at having other life-saving, non-addictive medications in mind for future development.

LinksEagle Care Health Solutions - https://eaglecarehealth.com/Auros Pharma - https://aurospharma.com/
Connect with Joseph on…LinkedIn - https://www.linkedin.com/in/joseph-nounou-md-mba-a83538a3LinkedIn - ​​https://www.linkedin.com/company/auros-pharma-llc/Facebook - https://www.facebook.com/profile.php?id=61567039824990